Mohieldin Elsayid1, Mohammed Jahman Al-Shehri1, Yasser Abdullah Alkulaibi1, Abdullah Alanazi2, Shoeb Qureshi3. 1. Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud Bin Abdul-Aziz University, Riyadh, Saudi Arabia. 2. Department of Emergency Medical Services, College of Applied Medical Sciences, King Saud Bin Abdul-Aziz University, Riyadh, Saudi Arabia. 3. Department of Research Methodology, College of Applied Medical Sciences, King Saud Bin Abdul-Aziz University, Riyadh, Saudi Arabia.
Abstract
BACKGROUND: Notwithstanding, the growing incidence of sickle cell hemoglobinopathies (SCH) such as sickle cell anemia (SCA) or sickle cell disease, sickle/beta-thalassemia; the exact prevalence remains obscure in Saudi Arabia. Hence, this study is an attempt to determine the frequency of SCA and sickle cell trait (SCT) among all anemic patients with SCH treated at the King Abdul-Aziz Medical City (KAMC), Riyadh, Saudi Arabia. Furthermore, the hemoglobin (Hb) S and other Hb patterns (Hb AS and Hb F) were also estimated in SCA and SCT patients. MATERIALS AND METHODS: Results of Hb capillary electrophoresis performed on all patients with SCH from January 2011 to December 2013 were evaluated retrospectively. RESULTS: Of a total of 3332 patient data analyzed, 307 were anemic patients (58% males and 42% females) with SCH. The sickling test showed all the patients to be positive. Hb electrophoresis revealed the incidence of 96.7%, 3.3%, and 0% of the patients suffered from SCA, SCT and sickle/beta-thalassemia, respectively. Patients with SCA had a higher level of Hb F and showed no crisis when compared with other SCA patients who had lower or no Hb F levels. CONCLUSION: SCA is relatively frequent among males (56.4%) than females out of all patients with SCH. The SCA incidence was more common (48.5%) among children, frequency of SCT among adult age group was 1.6%, while sickle/beta-thalassemia was 0%.
BACKGROUND: Notwithstanding, the growing incidence of sickle cell hemoglobinopathies (SCH) such as sickle cell anemia (SCA) or sickle cell disease, sickle/beta-thalassemia; the exact prevalence remains obscure in Saudi Arabia. Hence, this study is an attempt to determine the frequency of SCA and sickle cell trait (SCT) among all anemicpatients with SCH treated at the King Abdul-Aziz Medical City (KAMC), Riyadh, Saudi Arabia. Furthermore, the hemoglobin (Hb) S and other Hb patterns (Hb AS and Hb F) were also estimated in SCA and SCT patients. MATERIALS AND METHODS: Results of Hb capillary electrophoresis performed on all patients with SCH from January 2011 to December 2013 were evaluated retrospectively. RESULTS: Of a total of 3332 patient data analyzed, 307 were anemicpatients (58% males and 42% females) with SCH. The sickling test showed all the patients to be positive. Hb electrophoresis revealed the incidence of 96.7%, 3.3%, and 0% of the patients suffered from SCA, SCT and sickle/beta-thalassemia, respectively. Patients with SCA had a higher level of Hb F and showed no crisis when compared with other SCApatients who had lower or no Hb F levels. CONCLUSION:SCA is relatively frequent among males (56.4%) than females out of all patients with SCH. The SCA incidence was more common (48.5%) among children, frequency of SCT among adult age group was 1.6%, while sickle/beta-thalassemia was 0%.
Anemia is a condition in which the hemoglobin (Hb) concentration level is reduced. Sickle cell anemia is a disease of the blood, which is caused by an inherited Hb S gene.[1] Normal Hb consists of: Hb A, Hb A2 and Hb F, while a person with SCH has different Hb pattern.[2] In SCA the red blood cells are sickle or boat-shape.[3] Sickle Hb S is produced as a result of replacement of glutamic acid instead of valine in position number six of the β chain.[45] The abnormal red cells (sickle cells) can block small blood capillaries causing damage in tissues and organs, which leads to pain (crisis)[6789] increased extravascular destruction of red blood cells[10] and increased risk of severe dehydration.[11] SCA affects all age groups globally[1] with demographic variations. Children who are born with SCA inherit it from their parents. Persons who have the SCT or have SCA can be carriers of Hb S.[1213]Here, we determined the frequency distribution of SCA and SCT among anemicpatients attending at KAMC - Riyadh, Saudi Arabia to assess the distribution of the disease and identify carriers among the population.
MATERIALS AND METHODS
A retrospective chart review study was conducted to determine the frequency of SCA and SCT among anemic Saudi Arabianpatients. The study data were collected from hematology laboratory at KAMC, National Guard of Health Affairs Hospital complex in Riyadh, Saudi Arabia.Inclusion criteria: Male and female patients of all age groups who were diagnosed with anemia in the hematology laboratory from January 2011 to December 2013 were included.Exclusion criteria: Nonanemic patients or anemicpatients with anemia other than SCH were excluded.
Data collection methods, instruments used, measurements
A computer printout of demographic data and discharge clinical events/outcomes collected from records department for all episodes of hospital discharges that were coded for diagnosis of SCA or SCT were analyzed.
Data analysis
Study variables were directly entered into SPSS software, version 20 (The International Business Machines Corporation, New York). A backup soft copy version, as well as a hard copy print, was dated, saved and secured after each data entry update.Statistical analysis of study variables was performed using SPSS software version 20. SCA, SCT frequency and clinical outcomes at discharge were determined.
RESULTS
Out of 3332 anemicpatient's data analyzed, 307 were anemicpatients with SCH. The results of Hb electrophoresis showed 297 (96.7%) SCA, 10 (3.3%) SCT and sick/beta-thalassemiapatients (0%) [Figures 1 and 2]. Patients with SCA, who had high levels of Hb F did not have any crisis when compared with SCApatients with low or no Hb F levels [Table 1]. The SCA was highly frequent (56.4%) among males while among the females the incidence was 40.5% out of all patients with SCH [Tables 2 and 3]. In children, SCA was more commonly (48.5%) observed while SCT was only 1.0%. The frequency of SCA and SCT in adults was 36.25 and 1.6% respectively [Tables 4 and 5].
Figure 1
Frequency distribution of patients with hemoglobinopathies among anemic patients
Figure 2
Frequency of sickle cell anemia, sickle cell trait and sickle/beta-thalassemia among patients with sickle cell hemoglobinopathies
Table 1
Frequency of patient's crisis with respect to Hb patterns
Table 2
Frequency of Hb patterns among anemic patients with SCH
Table 3
Frequency of SCH with respect to gender
Table 4
Frequency of Hb patterns among SCA and SCT patients
Table 5
Frequency of SCA and SCT with respect to age groups
Frequency distribution of patients with hemoglobinopathies among anemicpatientsFrequency of sickle cell anemia, sickle cell trait and sickle/beta-thalassemia among patients with sickle cell hemoglobinopathiesFrequency of patient's crisis with respect to Hb patternsFrequency of Hb patterns among anemicpatients with SCHFrequency of SCH with respect to genderFrequency of Hb patterns among SCA and SCT patientsFrequency of SCA and SCT with respect to age groups
DISCUSSION
Sickle cell hemoglobinopathies involve SCA, the SCT, and sickle/beta-thalassemia. SCA and SCT are most common forms of Hb defect (Hb S gene), which are inherited by children from parents.[1415] SCH is one of the common health problems globally and in Saudi Arabia, where the gene frequency of this disease is highly prevalent.[16171819] In our study, we focused on SCA, SCT and the Hb patterns in each type of hemoglobinopathies in addition to age and gender of patients. The study group included 307 anemicpatients with SCH, the high frequency of SCA among SCH Saudipatients with homozygous sickle cell (Hb SS) and less frequent SCT with the heterozygous sickle cell (Hb AS). These proportions are consistent with previous reports.[2021] However, results of our study showed a high frequency of SCA (Hb SS) and SCT (Hb AS) among Saudi Arabian SCH patients. The high frequency of homozygous sickle cell (Hb SS) and heterozygous sickle cell (Hb AS) cases among the Saudi Arabian SCH population reflect the high frequency of Hb S gene, which may be due to consanguineous marriage, which is a common tribal tradition practice in this population.[2223] Additionally mild cases of SCA were also observed among adult patients. Some patients with SCA never had symptoms or crisis due to the presence of fetal Hb in high level.[24] Fetal Hb seems to protect the patients from disease severity and crisis. In our study, the majority of the SCApatients with (Hb SS) pattern had a severe crisis, and they tended to be more symptomatic. In contrast, the majority of SCApatients had (Hb S + Hb F) and these patients did not suffer from any crisis due to the presence of fetal Hb in an appropriate concentration.[2526] The level of fetal Hb in the blood circulation is very essential as they seem to protect the red blood cells from becoming sickle shape and hence prevent them from blocking the blood flow, especially in small capillaries.[26] We conclude that SCA is the most common type of hereditary anemia among the Saudi Arabian population. The distribution of Hb S among Saudi population illustrate that Hb AS predominates among family. High level of fetal Hb protects from disease crisis. The level of Hb S among individuals with SCA is gender and age independent. We recommend that family screening of the SCA and SCT is necessary to identify sickle cell carriers and should be extended to all areas, which have the high frequency of Hb S, and premarriage investigation should be considered as a routine investigation.
Authors: M A el-Hazmi; A S Warsy; N Bashir; A Beshlawi; I R Hussain; S Temtamy; F Qubaili Journal: East Mediterr Health J Date: 1999-11 Impact factor: 1.628
Authors: Maren Schulze; Ahmed Zidan; Mark Sturdevant; Sultan Aljudaibi; Mohammad Shagrani; Khalid Bzeizi; Saleh Alqahtani; Dieter C Broering Journal: Transplant Direct Date: 2022-05-09
Authors: Heba M Al-Qattan; Dana F Amlih; Fatima S Sirajuddin; Dalal I Alhuzaimi; Mai S Alageel; Reema M Bin Tuwaim; Farjah H Al Qahtani Journal: Adv Hematol Date: 2019-05-02
Authors: Zakaria M Alhawsawi; Amna M Alshenqeti; Amal M Alqarafi; Leema K Alhussayen; Waheed A Turkistani Journal: J Taibah Univ Med Sci Date: 2019-04-02
Authors: Abozer Y Elderdery; Abdullah Alsrhani; Badr Alzahrani; Muhammad Atif; Ahmed I Refaiy; Hussain Shiwani; Amin Abbas; Dawelbiet A Yahia Journal: Evid Based Complement Alternat Med Date: 2022-03-21 Impact factor: 2.629
Authors: Reem A Hejazi; Nameer A Mandourah; Aryaf S Alsulami; Hussain T Bakhsh; Reem M Diri; Ahmad O Noor Journal: Saudi Pharm J Date: 2021-02-16 Impact factor: 4.330